Skip to content

Medical-device intelligence

NGZ: Susceptibility Test Plate, Antifungal

FDA product code NGZ: Susceptibility Test Plate, Antifungal. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
NGZ
FDA device name
Susceptibility Test Plate, Antifungal
Device class
2
Regulation number
866.1640
Medical specialty
Microbiology
Review panel
MI

FDA definition

The device is an in vitro diagnostic device intended for use in determining quantitative susceptibility of Candida species to various antifungal agents diluted in varying concentration in a microtiter plate format.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

21 clearance records and 5 recall records in the covered releases, across 7 source company names and 1 product codes. Dated history runs from Oct 9, 2001 to Oct 19, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202601
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202601

Product codes represented

Code and FDA device nameClearancesRecalls
NGZ · Susceptibility Test Plate, Antifungal215

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

26 matching records
Device / recordCompany in FDA recordSourceSource date
Yeastone Broth, 11ML, 10/BOX, used in antibiotic susceptibility testing of mycological clinical specimensZ-0355-2027 · NGZRemel, IncRecallNov 3, 2026FDA classification date
Yeastone Broth, 11ML, 10/BOX YY3462Z-1806-2026 · NGZRemel, IncRecallApr 10, 2026FDA classification date
The Sensititre YeastOne Susceptibility System with Micafungin in the dilution range of 0.008-16 µg/mLK243738 · NGZThermo Fisher Scientific510(k)Feb 27, 2025FDA decision date
VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL)K232967 · NGZbioMerieux, Inc.510(k)Jun 12, 2024FDA decision date
VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL)K232963 · NGZbioMerieux, Inc.510(k)Jun 7, 2024FDA decision date
The Sensititre YeastOne Susceptibility System with Rezafungin in the dilution range of 0.008-8ug/mLK231433 · NGZThermo Fisher Scientific510(k)Aug 31, 2023FDA decision date
Sensititre YeastOne Susceptibility System with Fluconazole in the dilution range of 0.12-128ug/mLK221198 · NGZThermo Fisher Scientific510(k)Mar 10, 2023FDA decision date
The Sensititre YeastOne Susceptibility System with Caspofungin in the dilution range of 0.015-16ug/mlK221899 · NGZThermo Fisher Scientific510(k)Jan 20, 2023FDA decision date
VITEK 2 REAGENT AST-GP67 TEST KIT 20 CARDS, CATALOG 22226Z-0792-2023 · NGZBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL FLUCONAZOLE FL 256 US S30, CATALOG 412333Z-0824-2023 · NGZBiomerieux IncRecallJan 4, 2023FDA classification date
Sensititre YeastOne Susceptibility System with Voriconazole in the dilution range of 0.008 - 8 ug/mLK211539 · NGZThermo Fisher Scientific510(k)Dec 15, 2021FDA decision date
VITEK 2 AST-YS Micafungin (<=0.06 - =>8 µg/mL)K181368 · NGZbioMerieux, Inc.510(k)Jun 20, 2018FDA decision date
VITEK 2 Gram Fungal Susceptibility card (AST-YS05), REF 411945, 20 cards per carton.Z-2378-2017 · NGZBiomerieux IncRecallMay 22, 2017FDA classification date
VITEK 2 AST-Yeast Micafungin (0.06-8 mcg/mL)K151923 · NGZbioMerieux, Inc.510(k)Mar 25, 2016FDA decision date
VITEK 2 AST-YS Caspofungin <=0.125 - >=8 ug/mLK151817 · NGZbioMerieux, Inc.510(k)Feb 18, 2016FDA decision date
VITEK 2 AST YS FLUCYTOSINE, VITEK 2 AST YEAST FLUCYTOSINEK133952 · NGZbioMerieux, Inc.510(k)Aug 19, 2014FDA decision date
VITEK 2 AST - YEAST FLUCONAZOLEK133817 · NGZbioMerieux, Inc.510(k)Aug 5, 2014FDA decision date
SENSITITRE YEASTONE SUSCEPTIBILITY PLATESK133038 · NGZTrek Diagnostic Systems510(k)Jan 31, 2014FDA decision date
VITEK 2 YEAST CASPOFUNGINK101566 · NGZbioMerieux, Inc.510(k)Sep 28, 2010FDA decision date
VITEK 2 YEAST VORICONAZOLEK092454 · NGZbioMerieux, Inc.510(k)May 21, 2010FDA decision date
ETEST VORICONAZOLE 0.002-32 UG/MLK082534 · NGZAb Biomerieux510(k)Nov 2, 2009FDA decision date
SENSITITRE YEASTONE SUSCEPTIBILITY PLATESK090968 · NGZTrek Diagnostic Systems, Inc.510(k)Jun 4, 2009FDA decision date
SENSITITRE YEASTONE SUSCEPTIBILITY PLATES- ADDITIONAL ANTIMICROBICSK081063 · NGZTrek Diagnostic Systems, Inc.510(k)Mar 6, 2009FDA decision date
VITEK 2 AST-YS FLUCONAZOLEK061945 · NGZbioMerieux, Inc.510(k)Sep 19, 2006FDA decision date
ETEST FOR ANTIFUNGAL SUSCEPTTIBILITY TESTINGK040560 · NGZAb Biodisk510(k)Jul 27, 2004FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗